abstract |
Dosing regimens for the administration of complexes comprising IL-15/IL-I5Ra in combination nwith an anti-PD-i antibody molecule to patients are disclosed. Such dosing regimens can be used for npreventing, treating and/or managing disorders such as cancer. |